Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,269 | -102,658 | -67,762 | -29,657 | -71,454 |
| Depreciation Amortization | 1,986 | 1,384 | 919 | 458 | 1,230 |
| Accounts receivable | N/A | N/A | N/A | N/A | 5,000 |
| Accounts payable and accrued liabilities | -3,469 | 459 | 1,866 | -839 | 4,366 |
| Other Working Capital | -3,205 | 9,619 | 6,269 | -1,383 | 12,476 |
| Other Operating Activity | 16,272 | 9,735 | 4,499 | 3,820 | 2,661 |
| Operating Cash Flow | $-99,686 | $-81,461 | $-54,208 | $-27,601 | $-45,721 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -485 | -537 | -480 | -464 | -2,743 |
| Investing Cash Flow | $-485 | $-537 | $-480 | $-464 | $-2,743 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 964 |
| Debt Issued | 19,665 | 18,756 | N/A | N/A | N/A |
| Common Stock Issued | 142,201 | 120,502 | 90,004 | 46,016 | 40,677 |
| Other Financing Activity | -6,991 | -6,118 | -3,596 | -3,082 | -3,177 |
| Financing Cash Flow | $154,875 | $133,140 | $86,408 | $42,934 | $38,464 |
| Beginning Cash Position | 31,749 | 31,749 | 31,749 | 31,749 | 41,749 |
| End Cash Position | 86,453 | 82,891 | 63,469 | 46,618 | 31,749 |
| Net Cash Flow | $54,705 | $51,142 | $31,720 | $14,869 | $-10,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -99,686 | -81,461 | -54,208 | -27,601 | -45,721 |
| Capital Expenditure | -485 | -537 | -480 | -464 | -2,743 |
| Free Cash Flow | -100,170 | -81,998 | -54,688 | -28,065 | -48,463 |